SCHEMBL6180600

SCHEMBL6180600

C=C(Cl)C(=O)Nc1ccc2c(c1)CN(C(=O)Nc1cc(C(=O)Nc3cc(C(=O)Nc4cc(C(=O)NCCC(N)=O)n(C)c4)n(C)c3)n(C)c1)N2C

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HRAS P01112 14/20 0.43
ESR1 P03372 13/20 0.43
ESR2 Q92731 13/20 0.43
TOP1 P11387 2/20 0.43
KDM4E B2RXH2 1/20 0.43
POLB P06746 1/20 0.43
MAPT P10636 1/20 0.43
HIF1A Q16665 1/20 0.43
HDAC1 Q13547 2/20 0.32
HDAC2 Q92769 2/20 0.32
HDAC8 Q9BY41 2/20 0.32
CHRNA7 P36544 1/20 0.31
NAMPT P43490 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7116987 0.84 HRAS (0.57) HRASESR1ESR2TOP1KDM4E
SCHEMBL7128037 0.84 HRAS (0.57) HRASESR1ESR2TOP1KDM4E
SCHEMBL6176014 0.77 HRAS (0.62) HRASESR1ESR2TOP1KDM4E
SCHEMBL7116991 0.75 HRAS (0.53) HRASESR1ESR2TOP1KDM4E
SCHEMBL7124601 0.75 HRAS (0.53) HRASESR1ESR2TOP1KDM4E
SCHEMBL7119707 0.75 HRAS (0.57) HRASESR1ESR2TOP1KDM4E
SCHEMBL7127221 0.75 HRAS (0.57) HRASESR1ESR2TOP1KDM4E
SCHEMBL3677086 0.74 HRAS (0.56) HRASESR1ESR2TOP1KDM4E
Hydrochloric Acid SCHEMBL3454064 0.73 KDM4E (0.57) HRASESR1ESR2TOP1KDM4E
SCHEMBL6975216 0.73 HRAS (0.69) HRASESR1ESR2TOP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458768-B1 ANTITUMOR AGENTS THAT CAN BE FORMULATED WITH A COMPOUND ALTERNATIVELY, CAN BE ADMINISTERED IN A MIXTURE OF DRUGS PHARMACIA & UPJOHN, S.P.A. (IT) 2002-10-01 US claimed
EP-1064281-B1 BENZOHETEROCYCLIC DISTAMYCIN DERIVATIVES, PROCESS FOR PREPARING THEM, AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-05-25 EP disclosed
US-6458768-B1 ANTITUMOR AGENTS THAT CAN BE FORMULATED WITH A COMPOUND ALTERNATIVELY, CAN BE ADMINISTERED IN A MIXTURE OF DRUGS PHARMACIA & UPJOHN, S.P.A. (IT) 2002-10-01 US disclosed